|
1
|
Bolten WW, Gross M, Brabant T, Weck V and
Labenz J: Individual pain treatment with NSAIDs. MMW Fortschr Med.
15559–60. (62)2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ennis ZN, Dideriksen D, Vaegter HB,
Handberg G and Pottegard A: Acetaminophen for Chronic Pain: A
Systematic Review on Efficacy. Basic Clin Pharmacol Toxicol.
118:184–189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pasternak GW: When it comes to opiates,
just say NO. J Clin Invest. 117:3185–3187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
García Rodríguez LA and Jick H: Risk of
upper gastrointestinal bleeding and perforation associated with
individual non-steroidal anti-inflammatory drugs. Lancet.
343:769–772. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wiech K and Tracey I: The influence of
negative emotions on pain: Behavioral effects and neural
mechanisms. Neuroimage. 47:987–994. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Basbaum AI, Bautista DM, Scherrer G and
Julius D: Cellular and molecular mechanisms of pain. Cell.
139:267–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tovote P, Fadok JP and Lüthi A: Neuronal
circuits for fear and anxiety. Nat Rev Neurosci. 16:317–331. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wilhelmsen M, Amirian I, Reiter RJ,
Rosenberg J and Gögenur I: Analgesic effects of melatonin: A review
of current evidence from experimental and clinical studies. J
Pineal Res. 51:270–277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frange C, Hachul H, Tufik S and Andersen
ML: Circadian rhythms, insomnia and osteoarthritis pain. Chronobiol
Int. 32:1323–1324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Junker U and Wirz S: Review article:
Chronobiology: Influence of circadian rhythms on the therapy of
severe pain. J Oncol Pharm Pract. 16:81–87. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lucas RJ, Lall GS, Allen AE and Brown TM:
How rod, cone, and melanopsin photoreceptors come together to
enlighten the mammalian circadian clock. Prog Brain Res. 199:1–18.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Srinivasan V, Lauterbach EC, Ho KY,
Acuña-Castroviejo D, Zakaria R and Brzezinski A: Melatonin in
antinociception: Its therapeutic applications. Curr Neuropharmacol.
10:167–178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Danilov A and Kurganova J: Melatonin in
chronic pain syndromes. Pain Ther. 5:1–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reiter RJ: Melatonin: The chemical
expression of darkness. Mol Cell Endocrinol. 79:C153–C158. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pickard GE: Circadian rhythm of
nociception in the golden hamster. Brain Res. 425:395–400. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Srinivasan V, PandiPerumal SR, Spence DW,
Moscovitch A, Trakht I, Brown GM and Cardinali DP: Potential use of
melatonergic drugs in analgesia: Mechanisms of action. Brain Res
Bull. 81:362–371. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Axelrod J and Wurtman RJ: Photic and
neural control of indoleamine metabolism in the rat pineal gland.
Adv Pharmacol 6 (Pt A). 157–166. 1968. View Article : Google Scholar
|
|
18
|
Moore RY: Neural control of the pineal
gland. Behav Brain Res. 73:125–130. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Berson DM, Dunn FA and Takao M:
Phototransduction by retinal ganglion cells that set the circadian
clock. Science. 295:1070–1073. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klein DC, Schaad NL, Namboordiri MA, Yu L
and Weller JL: Regulation of pineal serotonin N-acetyltransferase
activity. Biochem Soc Trans. 20:299–304. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Becker-André M, Wiesenberg I,
Schaeren-Wiemers N, André E, Missbach M, Saurat JH and Carlberg C:
Pineal gland hormone melatonin binds and activates an orphan of the
nuclear receptor superfamily. J Biol Chem. 269:28531–28534.
1994.PubMed/NCBI
|
|
22
|
Mukherjee D, Roy SG, Bandyopadhyay A,
Chattopadhyay A, Basu A, Mitra E, Ghosh AK, Reiter RJ and
Bandyopadhyay D: Melatonin protects against isoproterenol-induced
myocardial injury in the rat: Antioxidative mechanisms. J Pineal
Res. 48:251–262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brydon L, Roka F, Petit L, de Coppet P,
Tissot M, Barrett P, Morgan PJ, Nanoff C, Strosberg AD and Jockers
R: Dual signaling of human Mella melatonin receptors via G(i2),
G(i3), and G(q/11) proteins. Mol Endocrinol. 13:2025–2038. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boutin JA, Audinot V, Ferry G and
Delagrange P: Molecular tools to study melatonin pathways and
actions. Trends Pharmacol Sci. 26:412–419. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marseglia L, D'Angelo G, Manti S, Aversa
S, Arrigo T, Reiter RJ and Gitto E: Analgesic, anxiolytic and
anaesthetic effects of melatonin: New potential uses in pediatrics.
Int J Mol Sci. 16:1209–1220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu CX, Zhu B, Xu SF, Cao XD and Wu GC: The
analgesic effects of peripheral and central administration of
melatonin in rats. Eur J Pharmacol. 403:49–53. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shavali S, Ho B, Govitrapong P, Sawlom S,
Ajjimaporn A, Klongpanichapak S and Ebadi M: Melatonin exerts its
analgesic actions not by binding to opioid receptor subtypes but by
increasing the release of beta-endorphin an endogenous opioid.
Brain Res Bull. 64:471–479. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lakin ML, Miller CH, Stott ML and Winters
WD: Involvement of the pineal gland and melatonin in murine
analgesia. Life Sci. 29:2543–2551. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mease P: Fibromyalgia syndrome: Review of
clinical presentation, pathogenesis, outcome measures, and
treatment. J Rheumatol Suppl. 75:6–21. 2005.PubMed/NCBI
|
|
30
|
Reiter RJ, AcunaCastroviejo D and Tan DX:
Melatonin therapy in fibromyalgia. Curr Pain Headache Rep.
11:339–342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song GH, Leng PH, Gwee KA, Moochhala SM
and Ho KY: Melatonin improves abdominal pain in irritable bowel
syndrome patients who have sleep disturbances: A randomised, double
blind, placebo controlled study. Gut. 54:1402–1407. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yousaf F, Seet E, Venkatraghavan L,
Abrishami A and Chung F: Efficacy and safety of melatonin as an
anxiolytic and analgesic in the perioperative period: A qualitative
systematic review of randomized trials. Anesthesiology.
113:968–976. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
ElShenawy SM, AbdelSalam OM, Baiuomy AR,
ElBatran S and Arbid MS: Studies on the anti-inflammatory and
anti-nociceptive effects of melatonin in the rat. Pharmacol Res.
46:235–243. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang T, Li SR, Dai X, Peng YL, Chen Q and
Wang R: Effects of melatonin on orphanin FQ/nociceptin-induced
hyperalgesia in mice. Brain Res. 1085:43–48. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Golombek DA, Escolar E, Burin LJ, De Brito
Sánchez MG and Cardinali DP: Time-dependent melatonin analgesia in
mice: Inhibition by opiate or benzodiazepine antagonism. Eur J
Pharmacol. 194:25–30. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ulugol A, Dokmeci D, Guray G, Sapolyo N,
Ozyigit F and Tamer M: Antihyperalgesic, but not antiallodynic,
effect of melatonin in nerve-injured neuropathic mice: Possible
involvements of the L-arginine-NO pathway and opioid system. Life
Sci. 78:1592–1597. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Naguib M, Baker MT, Spadoni G and
Gregerson M: The hypnotic and analgesic effects of
2-bromomelatonin. Anesth Analg. 97:763–768. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mantovani M, Kaster MP, Pertile R, Calixto
JB, Rodrigues AL and Santos AR: Mechanisms involved in the
antinociception caused by melatonin in mice. J Pineal Res.
41:382–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hernández-Pacheco A, Araiza-Saldaña CI,
Granados-Soto V and Mixcoatl-Zecuatl T: Possible participation of
the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in
the peripheral antinociception of melatonin. Eur J Pharmacol.
596:70–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
vanGeijlswijk IM, Korzilius HP and Smits
MG: The use of exogenous melatonin in delayed sleep phase disorder:
A meta-analysis. Sleep. 33:1605–1614. 2010.PubMed/NCBI
|
|
41
|
Braam W, van Geijlswijk I, Keijzer H,
Smits MG, Didden R and Curfs LM: Loss of response to melatonin
treatment is associated with slow melatonin metabolism. J Intellect
Disabil Res. 54:547–555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Appleton RE and Gringras P: Melatonin:
Helping to MEND impaired sleep. Arch Dis Child. 98:216–217. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hartz I, Furu K, Bratlid T, Handal M and
Skurtveit S: Hypnotic drug use among 0-17 year olds during
2004-2011: A nationwide prescription database study. Scand J Public
Health. 40:704–711. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Heussler H, Chan P, Price AM, Waters K,
Davey MJ and Hiscock H: Pharmacological and non-pharmacological
management of sleep disturbance in children: An Australian
Paediatric Research Network survey. Sleep Med. 14:189–194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Burgess HJ, Revell VL, Molina TA and
Eastman CI: Human phase response curves to three days of daily
melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab.
95:3325–3331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Reiter RJ, Tan DX and Galano A: Melatonin:
Exceeding expectations. Physiology (Bethesda). 29:325–333.
2014.PubMed/NCBI
|
|
47
|
Rovers J, Smits M and Duffy JF: Headache
and sleep: Also assess circadian rhythm sleep disorders. Headache.
54:175–177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Miano S, Parisi P, Pelliccia A, Luchetti
A, Paolino MC and Villa MP: Melatonin to prevent migraine or
tension-type headache in children. Neurol Sci. 29:285–287. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Peres MF, Zukerman E, da Cunha Tanuri F,
Moreira FR and Cipolla-Neto J: Melatonin, 3 mg, is effective for
migraine prevention. Neurology. 63:7572004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Klerman EB, Goldenberg DL, Brown EN,
Maliszewski AM and Adler GK: Circadian rhythms of women with
fibromyalgia. J Clin Endocrinol Metab. 86:1034–1039. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wikner J, Hirsch U, Wetterberg L and
Röjdmark S: Fibromyalgia - a syndrome associated with decreased
nocturnal melatonin secretion. Clin Endocrinol (Oxf). 49:179–183.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Citera G, Arias MA, MaldonadoCocco JA,
Lázaro MA, Rosemffet MG, Brusco LI, Scheines EJ and Cardinalli DP:
The effect of melatonin in patients with fibromyalgia: A pilot
study. Clin Rheumatol. 19:9–13. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hussain SA, AlKhalifa II, Jasim NA and
Gorial FI: Adjuvant use of melatonin for treatment of fibromyalgia.
J Pineal Res. 50:267–271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
deZanette SA, Vercelino R, Laste G,
Rozisky JR, Schwertner A, Machado CB, Xavier F, de Souza IC, Deitos
A, Torres IL, et al: Melatonin analgesia is associated with
improvement of the descending endogenous pain-modulating system in
fibromyalgia: A phase II, randomized, double-dummy, controlled
trial. BMC Pharmacol Toxicol. 15:402014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Konturek SJ, Konturek PC, Brzozowski T and
Bubenik GA: Role of melatonin in upper gastrointestinal tract. J
Physiol Pharmacol. 58(Suppl 6): 23–52. 2007.PubMed/NCBI
|
|
56
|
Lu WZ, Gwee KA, Moochhalla S and Ho KY:
Melatonin improves bowel symptoms in female patients with irritable
bowel syndrome: A double-blind placebo-controlled study. Aliment
Pharmacol Ther. 22:927–934. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Mozaffari S, Rahimi R and Abdollahi M:
Implications of melatonin therapy in irritable bowel syndrome: A
systematic review. Curr Pharm Des. 16:3646–3655. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Saha L, Malhotra S, Rana S, Bhasin D and
Pandhi P: A preliminary study of melatonin in irritable bowel
syndrome. J Clin Gastroenterol. 41:29–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Andersen LP, Werner MU, Rosenberg J and
Gögenur I: A systematic review of peri-operative melatonin.
Anaesthesia. 69:1163–1171. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Caumo W, Torres F, Moreira NL Jr, Auzani
JA, Monteiro CA, Londero G, Ribeiro DF and Hidalgo MP: The clinical
impact of preoperative melatonin on postoperative outcomes in
patients undergoing abdominal hysterectomy. Anesth Analg.
105:1263–1271. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mowafi HA and Ismail SA: Melatonin
improves tourniquet tolerance and enhances postoperative analgesia
in patients receiving intravenous regional anesthesia. Anesth
Analg. 107:1422–1426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ismail SA and Mowafi HA: Melatonin
provides anxiolysis, enhances analgesia, decreases intraocular
pressure, and promotes better operating conditions during cataract
surgery under topical anesthesia. Anesth Analg. 108:1146–1151.
2009. View Article : Google Scholar : PubMed/NCBI
|
